Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides*
暂无分享,去创建一个
[1] Balagurunathan Kuberan,et al. Enzymatic synthesis of antithrombin III–binding heparan sulfate pentasaccharide , 2003, Nature Biotechnology.
[2] D. Beeler,et al. Rapid two-step synthesis of mitrin from heparosan: a replacement for heparin. , 2003, Journal of the American Chemical Society.
[3] Zhengliang L. Wu,et al. The Involvement of Heparan Sulfate (HS) in FGF1/HS/FGFR1 Signaling Complex* , 2003, The Journal of Biological Chemistry.
[4] A. Malmström,et al. Heparan Sulfate 3-O-Sulfotransferase Isoform 5 Generates Both an Antithrombin-binding Site and an Entry Receptor for Herpes Simplex Virus, Type 1* , 2002, The Journal of Biological Chemistry.
[5] Balagurunathan Kuberan,et al. Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. , 2002, Journal of the American Chemical Society.
[6] Zhengliang L. Wu,et al. A new strategy for defining critical functional groups on heparan sulfate , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Selleck,et al. Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.
[8] J. J. Schwartz,et al. The Effect of Precursor Structures on the Action of Glucosaminyl 3-O-Sulfotransferase-1 and the Biosynthesis of Anticoagulant Heparan Sulfate* , 2001, The Journal of Biological Chemistry.
[9] J. Esko,et al. Cloning, Golgi Localization, and Enzyme Activity of the Full-length Heparin/Heparan Sulfate-Glucuronic Acid C5-epimerase* , 2001, The Journal of Biological Chemistry.
[10] K. Bame. Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. , 2001, Glycobiology.
[11] K. Kimata,et al. Substrate specificity of the heparan sulfate hexuronic acid 2-O-sulfotransferase. , 2001, Biochemistry.
[12] J. Esko,et al. Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4. , 2001, The Journal of biological chemistry.
[13] R. Linhardt,et al. Enzymatic modification of heparan sulfate on a biochip promotes its interaction with antithrombin III. , 2000, Biochemical and biophysical research communications.
[14] K. Yoshida,et al. The Occurrence of Three Isoforms of Heparan Sulfate 6-O-Sulfotransferase Having Different Specificities for Hexuronic Acid Adjacent to the TargetedN-Sulfoglucosamine* , 2000, The Journal of Biological Chemistry.
[15] K. Yoshida,et al. Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase-3A SulfatesN-Unsubstituted Glucosamine Residues* , 1999, The Journal of Biological Chemistry.
[16] R. Eisenberg,et al. A Novel Role for 3-O-Sulfated Heparan Sulfate in Herpes Simplex Virus 1 Entry , 1999, Cell.
[17] N. Copeland,et al. Multiple Isoforms of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase , 1999, The Journal of Biological Chemistry.
[18] J. J. Schwartz,et al. Expression of Heparan Sulfate d-Glucosaminyl 3-O-Sulfotransferase Isoforms Reveals Novel Substrate Specificities* , 1999, The Journal of Biological Chemistry.
[19] M. Götte,et al. Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.
[20] A. Lander,et al. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. , 1999, Glycobiology.
[21] I. MacRae,et al. Adenosine 5′-Phosphosulfate Kinase from Penicillium chrysogenum , 1998, The Journal of Biological Chemistry.
[22] U. Desai,et al. Mechanism of Heparin Activation of Antithrombin , 1998, The Journal of Biological Chemistry.
[23] M. Jalkanen,et al. Biosynthesis of Heparin/Heparan Sulfate , 1997, The Journal of Biological Chemistry.
[24] S. Stringer,et al. Specific Binding of the Chemokine Platelet Factor 4 to Heparan Sulfate* , 1997, The Journal of Biological Chemistry.
[25] J. J. Schwartz,et al. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? , 1997, The Journal of clinical investigation.
[26] D. Stephan,et al. Gene and other biological therapies for vascular diseases , 1997, Fundamental & clinical pharmacology.
[27] Jian Liu,et al. Purification of Heparan Sulfate D-Glucosaminyl 3-O-Sulfotransferase* , 1996, The Journal of Biological Chemistry.
[28] M. Salmivirta,et al. Heparan sulfate : a piece of information , 2004 .
[29] U. Lindahl,et al. Biosynthesis of heparin/heparan sulfate. Purification of the D-glucuronyl C-5 epimerase from bovine liver. , 1994, The Journal of biological chemistry.
[30] C. Hirschberg,et al. Molecular cloning and expression of a glycosaminoglycan N-acetylglucosaminyl N-deacetylase/N-sulfotransferase from a heparin-producing cell line. , 1994, The Journal of biological chemistry.
[31] U. Lindahl,et al. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions. , 1991, The Biochemical journal.
[32] D. Atha,et al. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. , 1987, Biochemistry.
[33] D. Atha,et al. Sequence variation in heparin octasaccharides with high affinity for antithrombin III. , 1984, Biochemistry.
[34] G. Torri,et al. Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III , 1984 .
[35] D. Atha,et al. Evaluation of critical groups required for the binding of heparin to antithrombin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[36] M. Schmidt,et al. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. , 1981, European journal of biochemistry.
[37] R. Rosenberg,et al. Anticoagulant Action of Heparin , 1973, Nature.
[38] R. Rosenberg,et al. The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.
[39] L. Fowler,et al. Studies on heparin degradation. I. Preparation of ( 35 S) sulphamate derivatives for studies on heparin degrading enzymes of mammalian origin. , 1971, Biochemical pharmacology.
[40] J. Shively,et al. Stoichiometry of the nitrous acid deaminative cleavage of model amino sugar glycosides and glycosaminoglycuronans. , 1970, Biochemistry.